Cargando…
Salivary Biomarkers in Lung Cancer
A very low percentage of lung cancer (LC) cases are discovered at an early and treatable stage of the disease, leading to an abysmally low 5-year survival rate. This underscores the immediate necessity for improved diagnostic, prognostic, and predictive biomarkers for LC. Biopsied lung tissue, blood...
Autores principales: | Skallevold, Hans E., Vallenari, Evan M., Sapkota, Dipak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528626/ https://www.ncbi.nlm.nih.gov/pubmed/34690552 http://dx.doi.org/10.1155/2021/6019791 |
Ejemplares similares
-
An Update on S100A16 in Human Cancer
por: Basnet, Suyog, et al.
Publicado: (2023) -
Graphene for Antimicrobial and Coating Application
por: Srimaneepong, Viritpon, et al.
Publicado: (2022) -
Response of human oral mucosal epithelial cells to different storage temperatures: A structural and transcriptional study
por: Yazdani, Mazyar, et al.
Publicado: (2020) -
Salivary Exosomes as Nanocarriers for Cancer Biomarker Delivery
por: Cheng, Jordan, et al.
Publicado: (2019) -
Bioactive Glass Applications in Dentistry
por: Skallevold, Hans Erling, et al.
Publicado: (2019)